Clinical Trials Directory

Intensified Pre-Operative Chemotherapy And Radical Surgery For High Risk Hepatoblastoma

RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. Giving chemotherapy drugs before surgery may shrink the tumor so that it can be removed. PURPOSE: This phase II trial is studying how well neoadjuvant chemotherapy works in treating young patients who are undergoing surgical resection for high-risk hepatoblastoma.

Stanford is not currently accepting new patients for this trial. You may want to check to see if other locations are recruiting.



  • drug : carboplatin
  • drug : cisplatin
  • drug : doxorubicin hydrochloride
  • procedure : adjuvant therapy
  • procedure : conventional surgery
  • procedure : neoadjuvant therapy

Phase: Phase 2


Ages Eligible For Study:

N/A - 17 Years

External Links

Explore related trials

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Peds Hem/Onc CRAs
Not Recruiting

Footer Links: